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ACUTE VIRAL HEPATITIS 
Clinical Course and Laboratory Aids in Diagnosis in Thirty-five Consecutive Cases 
Adrenal Steroid Therapy in Seven Cases 
HARVEY L . A T I N , M.D.* 
Introduction: 
The assertion has been made that the correct diagnosis of acute hepatitis can 
be made at the bedside by means of a careful history and physical examination in 
80 per cent of the patients who present themselves with this disease. With the aid of 
appropriate laboratory studies this percentage can be increased to 90. The percentage 
rises to 98 if liver biopsy is also employed.' Expectant treatment and observation 
along with patience, will add to the accuracy of diagnosis still further. In an attempt 
to assess the aid from laboratory diagnosis in this disease, and to evaluate the course 
o\ the patient and response to treatment. 35 consecutive patients with viral hepatiti.^  
and icterus were studied; these patients were admitted to the Henry Ford Hospita: 
dm ing 1956 and 1957. There w as no evidence of underlying chronic liver disease 
in this group. There were 22 males and 13 females and the cases were divided intr 
those due to infectious hepatitis virus (IH) and those due to homologous serun 
hepatitis virus (HSH). If the patient had received an injection from two weeks to 
six months prior lo the ons'^ l of his symptoms, he was considered to have serum 
hepatitis; we realize that this is not necessarily true, as the IH virus can be trans-
mitted also by the parenteral route. We arc also ayvare of the possibility that the IH 
and HSH viruses are not necessarily separate strains. 
The incubation period calculated from the time of the injection to the onset of 
symptoms, in the HSH group, varied from 35 to 147 days with an average of 80 days. 
The patient ranged from 8 to 67 years with an average age of 35 in the IH group 
compared with 52 in the HSH group. Not only were the patients in the latter group 
older, but the majority of them suffered from associated disease which necessitated 
Ihe previous blood or parenteral medication. Whether due to these reasons or due 
to the inherent greater virulence ot the B virus, as some have postulated, the patients 
with serum hepatitis appear to suffer a more severe form of the disease, as the data 
will indicate. It has long been said that scrum hepatitis has a more insidious onset, 
and this mav be reflected in the longer duration of symptoms prior to admission, i.e.. 
13 5 compared with 9.9 days. 
\ti lliod and Results: 
Many different methods could have been used to evalute the laboratory data. 
I he melhod used here was to record the peak abnormality, if any, and determine the 
number of days this occurred from the onset of symptoms and from the date of 
admission, and then note how long it look after onset of symptoms for this abnormality 
lo return to normal. The data has been summarized in Table I . 
•Kesutcnl. DiMsion of (iasiroenterolog\. 
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Table I 
Peak values of laboratory tests in 35 patients with viral hepatitis. 
V I R A L HEPATITIS 
35 Patients; 22 Males. 13 Females 
Number of Patients 
IH 
19 
HSH 
16 
Age (yrs.) 8 - 66 (Av. 35) 20 - 67 (Av. 52) 
Symptoms Prior to Admission (days) 1 - 28 (Av. 9.9) 4 - 28 (Av. 13.5) 
Bilirubin (mg.%) 2 - 15 (Av. 8.1) 6 - 46 (Av. 16.2) 
White Blood Count (x 1000) 3.3-11 (Av. 5.6) 4.5 - 10.5 (Av. 8.0) 
Ciiolesterol Esters (%) 21 - 58 (Av. 41) 24 - 63 (Av. 39) 
Prothrombin Time (%) Av. 91 Av. 82 
Alkaline Phosphatase (Bodansky units) 2.6 - 15.1 (Av. 7.4) 5.0 - 20 (Av. 9.5) 
Flocculation Tests 
Ceph. Choi. Flocculation 5/35 less than 3+ throughout course. 
fliymol Flocculation 6/35 less than 3-|- throughout cour.se. 
Thymol Turbidity (Units) 3/35 less than 4 throughout course. 
Av. 13.4 Av. 11.9 
Bilirubin: 
In HSH the bilirubin peaks were generally much higher (reaching 46 mg. per 
cent in one case) and, although generally occurring in the first week in the hospital, 
frequently took much longer (up to 21 days after admission or 31st day of iflness). 
In IH the peaks were lower, rarely over 12 mg. per cent, and usually but not invariably 
occurred within the first week in the hospital. 
While Blood Count: 
In no patient was there a white blood count above 11,000. Sevaral patients had 
white blood counts below 5,000, particularly in the IH group. The absence of prominent 
leukopenia in the HSH may be due to the longer duration of the illness prior to 
admission and testing. A white blood count of over 11,000 in uncomplicated viral 
hepatitis is extremely unusual. 
Cholesterol esters: 
The esters were usually below 50 per cent in 2/3 of the patients. The sickest 
patients usually had the lower values, but there is not enough data or correlation to 
make any further statement in this regard. 
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Proihiomhin Time: 
Tne lowest value was 41 per cent and only two patients had values below 55 per 
cent. This should not detract from the great prognostic value of a markedly abnormal 
prothrombin time in hepatitis. A value below 20 per cent is a grave sign of a severely 
diseased liver. 
.Alkaline Phosphatase: 
There was great variability in the peak values obtained and the number of days 
required for the peak to be reached. In 24 patients with two or more determinations, 
five reached values greater than 12 Bodansky units, i.e., approximately 20 per cent 
reached values in the range of so-called obstructive jaundice. 
Flocculation Tests: 
Approximately 17 per cent of the patients had one test negative and about 
12 per cent had two out of the three tests negative throughout the course of the 
illness. Only one patient, or about 3 per cent, had all tests negative throughout the 
course of the illness. Two patients, or about 6 per cent, had all tests negative during 
the first week in the hospital. Generally the cephalin cholesterol flocculation is the 
lirst and the thymol turbidity the last of these tests to be elevated. 
Serum Iron and Seruin Glutamic Oxtiloacetic Transaminase: 
According to Rinaldo, in jaundiced patients, values of serum transaminase greater 
than 250 units and serum iron greater than 200 micrograms are almost diagnostic 
of hepatitis.' Both tests appear to be of particular value early in the disease. About 
60 per cent of those tested reached serum transaminase levels greater than 250 units, 
.md 33 per cent serum iron levels greater than 200 micrograms per cent. Since many 
were admitted some time after the onset of the disease, these percentages are probably 
far lower than the true yield. The transaminase value in those with serial tests reached 
the peak about the 16th or 17th day of the illness or within the first week of hospitaliza-
tion. Since elevated serum transaminase levels did occur in patients with the cholan-
uiolitic variety of hepatitis, a serum transaminase level greater than 250 units, even 
in the presence of a high alkaline phosphata.se and negative flocculation tests, still points 
strongly to the diagnosis of hepatitis. 
Serum Protein: 
1 olal serum proteins and A/ G ratios were done on many patients but were all 
normal. This docs not detract from the value of low total protein and particularly 
a low albumin as an indication of a poor prognosis in patients with hepatitis. Further-
more, although no electrophoretic data was obtained on our patients, it is worth 
nientionini; that a rising gamma globulin is frequently associated with prolonged and 
chronic hepalitis. while a markedly elevated alpha globulin level is usually indicative 
of extra hepatic obstructive jaundice or metastatic disease in the liver, rather than 
hepatitis.' 
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iiliary drainage and Oral Cholecystograins: 
There were nine biliary drainages performed. Five of these could be considered 
abnormal by usual criteria, but only one had calcium bilirubinate pigment. In no 
e^ were there both cholesterol crystals and bilirubinate pigment. Three of these 
nine cases had cholecystograms. Two of these confirmed negative biliary drainage 
lindings. The other case yielded a negative cholecystogram in a patient with micro-
calculi in the biliary drainage. Of the five oral cholecystograms performed, (these 
were performed when jaundice was minimal), onlv one patient had an abnormal 
x-ray. That was a patient in whom calculi were demonstrated and who had classical 
biliary colic while in hospital. It is difficult to draw any conclusions from this data 
hut it is suspected that the biliary drainage must be interpreted with caution in patients 
with hepatitis. 
( •'iiiplete Suppression of Bile Flow: 
Twenty-nine patients had urinary urobilinogen or stool bile examinations on one 
more occasions. There were 13 patients or about 40 per cent who exhibited 
complete suppression of bile flow at some time during their course. Five patients, or 
It 16 per cent, had complete suppression for greater than 10 days. The longest 
'd of complete suppression in this series was 17 days. The frequency of prolonged 
biliary suppression in this series again calls to our atlcnlion the fact that suppression 
for more than ten days does not preclude a diagnosis of hepatitis. 
Liver Biopsy: 
The histological features of viral hepatitis during Ihe acute stage can be simply 
ilcseribed as variations and degree of two features: diffuse portal area exudate and 
parenchymal cell injury.* The diffuse portal exudate usually consists of leukocytes 
and a few eosinophiles. The parenchymal injury may he manifested by focal necrosis 
and lymphocyte satellitosis, acidophilic bodies, balloon cells, distortion of liver columns 
in the acute stage and by mitosis, pseudo-acini, lipofuscin pigment in Kupffer cells 
and bile stasis in the subsiding stage. During the latter part of the illness, the portal 
exudate and lipofuscin pigment may be the only evidence of liver pathology. 
Liver biopsy has been said to be about 90 per cent effective in the differential 
diagnosis of jaundice.* Of the 35 patients studied, ten or about 30 per cent, had 
a liver biopsy performed. Almost all of the biopsies were done during the resolving 
stage of the disease, and in only three, or less than 10 per cent, did they appear lo 
be necessary for diagnosis. One biopsy revealed normal liver tissue. The other nine 
"eie reported as showing hepatitis. All of these revealed periportal lymphocytes in 
moderate numbers and a few leukocytes. Four revealed marked focal aggregations 
of lymphocytes and a few leukocytes in the parenchyma. Only two revealed focal 
necrosis of liver cells and a similar number showed marked cholestasis. In four patients, 
there was evidence of liver cell regeneration. There was mild portal fibrosis in two 
patients, both of whom had HSH with marked cholestasis. There was no evidence of 
bile duct proliferation, bile lakes and feathery degeneration, so frequently seen in the 
v-'Mrahepatic variety of obstructive jaundice. 
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Vt^^^^Treatn^ent. Course and Prognosis: 
All of the patients were treated with high-protein, high-carbohydrate diets, vitamins, 
and enforced bed rest, during the acute stage of the disease. Some received lipotropic 
.igents. liver extract, and parenteral fluids, carbohydrates and vitamins, as necessary. 
Two patients received steroids, and their course will he discussed later. 
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Table I I 
I aboratory and clinical course in days in 32 patients with acute hepatitis. 
('ourse: 
1 lom lable II we note again the increased severity of the disease in HSH 
compared with IH. The bilirubin, transaminase and thymol turbidity peaks are 
iisii.ilh reached in that order during the first week in the hospital. Towards the end 
of the first week or the beginning of the second week in the hospital, the patient's 
.ippctite and sense of well being begin to show a definite improvement. Transaminase 
appears to be the first of the laboratory tests to return to normal (about 31 days 
trom onset of symptoms) and a persistent elevation in this test usually indicates 
continued hepatic disease. A secondary rise in the serum lransamina.se during the 
recovery phase usually indicates a relapse, and heralds a prolonged or chronic disease. 
Ihe hilinihm ,ind thymol turbidity take longer periods to reach normal levels. The 
ihvmol turbidity is usually the last to return to normal, not doing so until usually 
the latter part of the second month of the illness in the average case. It should be 
realized, however, that the thymol turbidity may not return to normal for several 
months alter all the other tests have done so. The total duration of the illness in the 
.i\er.ige case is about eight weeks in uncomplicated infectious hepalitis. compared 
with more than ten weeks in HSH. 
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There were three patients who after one year continued to have elevated floc-
ition tests and suggestive evidence at least of chronic hepatitis. This percentage 
bout 10 per cent is higher than usually expected with this disease. If we omit the 
padents suspected of having chronic hepatitis, we find that two. or six per cent 
approximately, of the remaining 32 suffered mild transient relapses. This percentage 
I imilar to that reported by Ducci.' No patient in this series died. 
Although the laboratory is a useful tool in the diagnosis and treatment of viral 
I atitis, it still remains bul an adjunct to the all important bedside wisdom that 
c only be obtained by .seeing and talking to the patient. 
^ ROID THERAPY 
Of the patients seen at the Henry Ford Hospital with viral hepatitis about 60 
per cent are males. During the past two years, seven cases have been treated with 
si nds. Of these, six or 86 per cent were females. This appears to indicate the 
II se follows a more severe course in the female patient. Of the seven, three were 
II cd with steroids because of delay in the onset of the recovery phase, i.e. persistent 
sing bilirubin and transaminase peaks and persistent complete intrahepatic biliary 
ol Liction. These patients, however, were reported as "feeling and eating well", 
pr r lo the onset of steroids, and the steroids were used in an attempt to "break 
III Ihe disease process". In an attempt to evaluate the course of this group, they 
v compared with three patients not treated with steroids, who had exhibited 
complete intrahepatic biliary obstruction for more than ten days. From Table I I I , 
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W E E K S 
Compariiion of the courses of the steroid and non-steroid treated patients. 
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we note that the two groups were similar with reference to transaminase peaks and 
days of complete biliary obstruction. The only significant difference was that two 
of the steroid group had exhibited transient lethargy five and seven days prior to its 
use. This indicates to a certain extent a more serious clinical state and will be 
commented upon later. The apparent lower bilirubin peaks in the steroid group mav 
be due to the effect of steroids in lowering serum bilirubin. There was a definite 
decrease in liver size and tenderness along with a 50-60 per cent drop in total serum 
bilirubin within 72 hours of starting the steroids. This was associated with definitj 
evidence of bilirubin in the stool within 48 hours. Although all patients in this group 
were apparently feeling and eating well, there was a clearcut added surge of well 
being, to the point of euphoria at times, and increased appetite, within 24 hours. 
There is some evidence that steroids do decrease the inflammatory reaction in the 
liver, and may improve bile flow by this method.' There is, however, some other 
unknown mechanism by which the serum bilirubin level is lowered, since this occurs 
even though bile flow obstruction persists, as noted in the fourth case. The longer 
period of transaminase elevation in the treated group indicates these drugs do not 
prevent continued hepatic cell injury and this point should be kept in mind when 
considering their use in the hepatic coma of viral hepatitis. In spite of the sudden 
prompt drop in bilirubin with the use of steroids, there is apparently no significant 
difference in Ihe period required for the total bilirubin to return to normal or in the 
total duration of the illness in the two groups. Doses of 300-400 mg. of cortisone, 
or its equivalent dropped gradually over a period of 7-14 days to maintenance levels, 
appears to be adequate when these drugs are used for the reasons described above. 
There was one mild relapse in the control group and one relapse with prolonged 
recovery in the steroid group. Recrudescences can develop in both groups and occur 
while the dose is being decreased or at termination of therapy in the steroid group. 
The reported relapse rate is about 20 per cent in the steroid treated group and about 
5 per cent in those not treated with steroids.' 
A fourth patient has been grouped separately. Her disease began in a mild 
manner about five weeks before. She had carried out strenuous activity during this 
period, and from her history we considered her to have a severe exacerbation of the 
disease. While in hospital her appetite and well being decreased and bile disappeared 
from the stool. Her sensorium. however, remained good. Because of the progressive 
nature of the disease, she was started on 400 mg. of cortisone daily. The total serum 
bilirtibin eiroppcd from 27 to 21 mg. and her appetite and weW being improved within 
72 hours. Bilirubin continued to be absent in the stool for the next 14 days, however, 
and no further drop in total serum bilirubin occurred during this time. Once the 
bilirubin began to appear in Ihe stool the serum bilirubin gradually decreased. After 
three weeks the patient is still on 200 mg. of cortisone daily and continues to gradually 
improve, although her progress has been slightly marred by transient hypomania and 
persisting euphoria. The early mild fall in serum bilirubin probably had nothing to 
do with hepatic function. The persistent absence of bilirubin in the stool and absence 
of progressive fall in serum bilirubin over two weeks can be considered as a partial 
tailure of steroid therapy. 
The other three patients who were treated with steroids exhibited progressive 
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idence of liver decompensation, manifested by lethargy and restlessness, decreasing 
\ ;11 being, appetite, albumin, prothrombin and cholesterol esters, and increasing 
bilirubin and transaminase. They could be classed as the pre-coma stage of liver 
, compensation. 
Two of these were started on what might be considered average doses of steroids, 
that is, 400 mg. or less of cortisone or its equivalent. Both exhibited transient im-
provement in appetite, sensorium and general well being. In one patient, this lasted 
only 24 hours and the patient subsequently expired on the twelfth day of steroids, 
despite antibiotics and arginine. This patient had exhibited progressive lethargy for 
three days, ascites, shrinking liver, and abdominal distention prior to the use of 
steroids. At post mortem, the patient was found to have diffuse and almost total 
hepatic necrosis and superficial gastric ulcers, with moderately severe upper gastro-
intestinal bleeding. The possible role of the steroids in the GI bleeding is of interest, 
but any answer at present can only be speculative in this regard. The other patient 
had a fluctuant course with ups and downs of lethargy, state of appetite, and well 
being for five days prior to steroids. She showed a good response to steroid therapy 
with marked increase in well being, sensorium, and appetite within 24 hours, and 
clearing of the obstructive phase with a 60 per cent drop in bilirubin within 72 hours. 
After 11 days of steroids, when the dose of cortisone was down to 50 mg. daily, she 
developed a relapse, associated with decreased appetite and well being, rising bilirubin 
and transaminase, and recurrence of the obstructive phase. The dose was then increased 
to 800 mg. daily with increase in appetite and well being and cessation of the 
obstructive phase within 72 hours. The transaminase, which after rising had begun 
to fall prior to the increase in dosage, continued to fall to normal levels in an un-
interrupted fashion. The serum bilirubin level, however, remained elevated without 
significant change for almost three weeks. The total serum protein continued to fall 
to a low of 4.8 grams per cent over the next two weeks, in spite of doses of cortisone 
ranging from 800 to 400 mg. daily. After five weeks on high doses of cortisone, only 
complicated by mild depression and homesickness, the patient was discharged on 
200 mg. of cortisone, eating well, with increasing energy, but still manifesting visible 
but mild icterus. Although the cortisone resulted in clinical improvement and appeared 
to stop and reverse the clinical downward trend of the illness, it did not result in 
sufficient laboratory evidence to indicate improvement in hepatic function and was 
associated with a clinical exacerbation when the dose was being lowered. 
The third patient treated in the pre-coma stage was started on 800 mg. of 
cortisone daily. She had exhibited progressive hepatic deterioration at another hospital 
in spite of 15 mg. of meticorten daily. When first seen at Henry Ford Hospital, a 
"hepatic flap" could already be demon.strated. There was no change in the downhill 
course with increase in steroid dosage and the patient expired several days later. A 
request for post mortem examination was denied. 
The work of Ducci indicating the value of high doses of cortisone (1 gram of 
cortisone or its equivalent) in hepatic coma due to viral hepatitis has been an 
important contribution to the treatment of this almost invariably fatal situation. 
Evidence to date, however, indicates that lower, more average do.ses of these steroids 
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will not alter the outcome of the patient in the coma stage. The doses appreniK 
must be high. I urihermore. Ihe earlier the steroids are used, the greater the chance 
of survival. The importance of low albumin and prothrombin levels as indicators ol 
hepatic disease does not require re-emphasis al this time. It is interesting to note, how-
e\er. that only two patients in the original series of 35 exhibited lethargy and both of 
these received steroids later, after Ihe lethargy had cleared, but when they exhibited a 
failure lo enter Ihe recovery stage of the ailment. Since lethargy occurs when the 
liver is severely diseased and had appeared from three to seven days prior to the date 
of beginning of steroid therapv in five out of seven of our patients, we may in thi; 
sign find one of the important indicators for those patients who should receive steroids 
l l is. therefore, suggested that any lethargy, severe enough to be clinically evident 
sluHild be met wilh steroid therapy. The dose at this point should be about 400 mg 
of cortisone daily or its equivalent. If the lethargy progresses or clinical state remain, 
stationary after 48 hours, then Ihe daily dose should be increased to 800 lo 1000 mg. 
Conclusions: 
From the work lo dale. Ihe routine use of steroids in acute, benign, viral hepatitis 
seems inadvisable.' Its use in the patient wilh persistent, complete, intrahepatic biliar. 
obstruction or cholangiolilic hepatitis is open lo question. If Ihe patient appears to 
be handling the elisease well in spile of the absence of bilirubin in the stool, since we 
ire probably not improving liver function or shortening significantly the total duratio.i 
of the illness with the use of these drugs, the decision lo employ them must be 
weighed very carefully. The possibility of untoward effects of steroid therapy along 
with a false sense of improvement must be weighed against Ihe possible good results 
of their use. 
Steroid therapy does dcfinitcb appear lo be indicated in Ihe patient with prolonged 
and/or progressive liver disease elite to acute viral hepatitis. The patient's ability to 
handle and respond to the disease appears to be the prime consideration here. The 
important factor is the patient himselL and the decision to use steroids must he made 
ll the bedside where clinical judgment must take precedence over results of laboratory 
tests. The use of steroids in the pre-coma and coma stages of acute hepatitis has 
already been discussed and appears well established al present. 
I he lendencN fe^ r the disease to run a more severe course in the female and the 
ellectiveness of steroids in many severely ill patients with acute hepatitis brings into 
locus once more the interrelationship of the cndocrines and the liver. Would the 
use of steroids, other than ailrenal. e.g. androgens, be more effectual in the treatment 
ot viral hepatitis'.' 
SUMMARY: 
I hirlv-five consecutive cases of acute viral hepatitis have been studied in an 
attempt lo determine the averiige clinical and laboratory course of the disease. The 
l.iboralorv tests iisetul in iliagnosis and in following the course of the disease are 
siresseil. 
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Seven cases of acute viral hepatitis treated with steroids are carefully evaluated 
d the relative value of these agents under various circumstances is discussed. 
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